Chemical Compound
7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-(5Z)-5-heptenoic acid 1-methylethyl ester; [1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-Heptenoic acid 1-methylethyl ester; AL 6221; Travaprost; Travatan; Travatanz; Travoprost
CAS Registry Number
157283-68-6
Primary record
7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-(5Z)-5-heptenoic acid 1-methylethyl ester; [1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-Heptenoic acid 1-methylethyl ester; AL 6221; Travaprost; Travatan; Travatanz; Travoprost
- 库存
- 9,107 克
- 纯度
- 99.7 %
- CAS
- 157283-68-6
化合物标识与属性
- CAS
- 157283-68-6
- PubChem CID
- 5282226
- SMILES
- CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)O)O
- Canonical SMILES
- CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O
名称与同义词
- Travoprost
- Travatan
- Travatan Z
- Izba
- Travaprost
- Travatanz
- 157283-68-6
- travoprostum
- Otx-tp
- Travatan Alcon
- Travoprost [USAN]
- Trovoprost
- Z, Travatan
- Travatan (TN)
- IDOSE TR
- 15S-Travoprost
- Travoprost in bulk
- AL-6221
- Travatan Z (TN)
- Travatan, Travoprost
- Travoprost Ophthalmic
- Travoprostintermediates
- Travoprost (Standard)
- TV-BK (Travoprost)
- Travoprost Intracameral
- AC1NQZOS
- RefChem:56256
- TRAVOPROST [MI]
- C26H35F3O6
- AL6221
- TRAVOPROST [INN]
- TRAVOPROST [JAN]
- UNII-WJ68R08KX9
- WJ68R08KX9
- Travoprost (Isomer Free)
- TRAVOPROST [VANDF]
- D09CZA
- Fluprostenol isopropyl ester
- TRAVOPROST [MART.]
- CHEBI:746859
- MKPLKVHSHYCHOC-AHTXBMBWSA-N
- TRAVOPROST [USP-RS]
- TRAVOPROST [WHO-DD]
- SCHEMBL93818
- Travoprost (JAN/USP/INN)
- Travoprost (JAN/USAN/INN)
- TRAVOPROST [EMA EPAR]
- Travoprost Ophthalmic Solution
- (+)-Fluprostenol isopropyl ester
- DTXSID80896948
- MFCD03411995
- DUOTRAV COMPONENT TRAVOPROST
- GTPL7102
- orb1301441
- orb3025009
- Travoprost [USAN:USP:INN:BAN]
- CHEMBL1200799
- NSC-760366
- SCHEMBL29830793
- TRAVOPROST [ORANGE BOOK]
- AL 6221
- HY-B0584R
- S01EE04
- DTXCID401326382
- GLXC-23326
- TRAVOPROST [USP MONOGRAPH]
- EX-A1772
- HY-B0584
- MSK15028
- ZINC4474682
- BDBM50248302
- EBC-27241
- s3738
- AKOS024458039
- C26-H35-F3-O6
- AC-6103
- ACN-040046
- AM84515
- CCG-269692
- CID5282226
- CS-2773
- DB00287
- FT28371
- NSC 760366
- RP17770
- CID:5282226
- NCGC00346741-02
- AN-10392
- BS-15509
- FT104213
- M978
- SC-50922
- SY028641
- Travoprost Ophthalmic Solution, 0.004%
- SID:283537565
- AB2000145
- LS-173521
- NS00007104
- Z6131
- (Z)-isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
- Fluprostenol isopropyl ester;AL6221;Flu-Ipr
- J1.152.432J
- Travoprost Ophthalmic Solution USP, 0.004%
- A12104
- D01964
- SBI-0654083.0001
- propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
- 283T686
- A809828
- C438103
- EN300-21831206
- SR-01000942266
- SR-01000946860
- (((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester
- Q2193376
- SR-01000942266-1
- SR-01000946860-1
- BRD-K23976833-001-01-0
- Fluprostenol isopropyl ester, >=98%, ethanol solution
- (1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-Dihydroxy-2-(3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester
- 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-, 1-methylethyl ester, (5Z)-
- D000069557
- propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl]cyclopentyl]hept-5-enoate
- Travoprost Ophthalmic Solution USP, 0.004% Travoprost
- B0084-059917
- (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3R)-3-hydroxy-4-((alpha,alpha,alpha-trifluoro-m-isopropyl-tolyl)oxy)-1-butenyl)cyclopentyl)-5-heptenoate
- 5-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl ester, (5Z)-
- 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl ester, (1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-
- isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate
- propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoate
- 5-Heptenoic acid,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-,1-methylethyl ester,(5Z)
- isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
- isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
- (+)-16-[3-(trifluoromethyl)phenoxy]-17,18,19,20-tetranorprostaglandin F2alpha isopropyl ester
- (1R-(1.ALPHA.(Z),2.BETA.(1E,3R*),3.ALPHA.,5.ALPHA.))-7-(3,5-DIHYDROXY-2-(3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOIC ACID, 1-METHYLETHYL ESTER
- (5Z)-7-[(1R)-2beta-[(1E,3R)-3-Hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]-3alpha,5alpha-dihydroxycyclopentan-1alpha-yl]-5-heptenoic acid isopropyl ester
- (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoic acid 1-methyethyl ester
- (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid isopropyl ester
- (Z)-isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl) phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
- (Z)-isopropyl7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
- 157283-72-2
- 208111-98-2
- 340181-93-3
- 4-(3-hydroxy-3-methyloct-1-enyl)-5-(7-phosphanylidene-7-propan-2-yloxyhept-2-enyl)cyclopentane-1,3-diol
- 5-Heptenoic Acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl Ester,(5Z)-
- 7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-(5Z)-5-heptenoic acid 1-methylethyl ester; [1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-Heptenoic acid 1-methylethyl ester; AL 6221; Travaprost; Travatan; Travatanz; Travoprost
- ISOPROPYL (Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATE
- ISOPROPYL (Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-((alpha,alpha,alpha-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATE
- Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R,E)-3-hydroxy-4-(3-(trifluoromethyl)-phenoxy)-but-1-enyl)-cyclopentyl)-hept-5-enoate
- Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(R,E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoate
- propan-2-yl (5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate